Ractigen Therapeutics
Ractigen is an early-stage pharmaceutical company.
Ractigen is an early-stage pharmaceutical company.
Ractigen Therapeutics has raised $31.0M across 1 round. Its most recent round was a Series Unknown of $31.0M in Jul 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Ractigen Therapeutics is featured in
Similar companies
Kanurra is a pass-through pharmacy benefit manager for self-funded and level-funded companies.
Hongde New Materials produces thermoplastic composite materials with fiber reinforcement.
Phil Rivers Technology is an AI pharmaceutical R&D solution provider.
Guangna Development is an optoelectronic device seller.
Tongchuang Yongyi is the developer of an enterprise IT platform providing cloud, disaster recovery, and IT asset management solutions.
PMT Technologies is a measurement technology company with full independent research and development and production capabilities.
iSpace designs and develops commercial space shuttle.
Kaiwang Data is a one-stop shop for data solutions.
Demark provides professional high-precision machining services to consumers.
PaXini Tech is a research and development company for tactile technology and adaptive robots.
GCL Optoelectronics develops perovskite photovoltaic technologies and manufactures solar modules for renewable energy generation.
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.